TG Therapeutics (TGTX) Misses Q2 EPS by 8c

TG Therapeutics (NASDAQ: TGTX) reported Q2 EPS of ($0.38), $0.08 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters